Skip to Content

Hearings

Why Does the U.S. Department of Veterans Affairs Continue to Give a Suicide–Inducing Drug to Veterans with Post Traumatic Stress Disorder?

Wednesday, July 9, 2008 | 10:00 AM Room 334 Cannon House Office Building

Opening Statement

Hon. Bob Filner Chairman, and a Representative in Congress from the State of California
Hon. John T. Salazar, a Representative in Congress from the State of Colorado
Hon. Steve Scalise, a Representative in Congress from the State of Louisiana
Hon. Steve Buyer, Ranking Repubican Member, and a Representative in Congress from the State of Indiana
Hon. Harry E. Mitchell, a Representative in Congress from the State of Arizona

Panel: 1

James G. Elliott, (Iraq War Veteran), Silver Spring, MD

Accompanied By:

Tammy R. Hilburn, Silver Spring, MD

Lieutenant Colonel Roger G. Charles, USMC (Ret.), and Editor, DefenseWatch, Vice-Chairman, Board of Trustees, Soldiers for the Truth Foundation, on behalf of Eilhys England Hackworth, Chairperson, Board of Trustees, Soldiers for the Truth Foundation

Panel: 2

Hon. James B. Peake, M.D., U.S. Department of Veterans Affairs, Secretary

Accompanied By:

Joel Kupersmith, M.D., Veterans Health Administration, Chief Research and Development Officer, U.S. Department of Veterans Affairs

J. Thomas Puglisi, Ph.D., CIP, Veterans Health Administration, Chief Officer, Office Research Oversight, U.S. Department of Veterans Affairs

Miles McFall, Ph.D., Veterans Affairs Puget Sound Health Care System, Director, Post-Traumatic Stress Disorder Treatment Programs, Veterans Health Administration, U.S. Department of Veterans Affairs

Paul Seligman, M.D., M.P.H, Center for Drug Evaluation and Research, Associate Director of Safety Policy and Communication, Food and Drug Administration, U.S. Department of Health and Human Services

Accompanied By:

Robert Temple, M.D., Center for Drug Evaluation and Research, Director, Office of Medical Policy, Food and Drug Administration, U.S. Department of Health and Human Services

Panel: 3

Ponni Subbiah, M.D., M.P.H., Pfizer Inc., New York, NY, Vice President, Medical Affairs

John D. Daigh, Jr., M.D., CPA, Office of Inspector General, Assistant Inspector General for Healthcare Inspections, U.S. Department of Veterans Affairs

Accompanied By:

Andrea Buck, M.D., JD, Office of Healthcare Inspections, Senior Physician, Medical Consultation and Review Division, Office of Inspector General, U.S. Department of Veterans Affairs

Randall Snow, Office of Healthcare Inspections, Associate Director, Washington, DC, Regional Office, Office of Inspector General, U.S. Department of Veterans Affairs

Submissions for the Record

Gerald P. Koocher, Ph.D.

Why Does the VA Continue to Give a Suicide–Inducing Drug to Veterans with PTSD?

Printed Hearing Text

Printed Hearing PDF